209 related articles for article (PubMed ID: 15368299)
1. Association of hepatitis C virus envelope proteins with exosomes.
Masciopinto F; Giovani C; Campagnoli S; Galli-Stampino L; Colombatto P; Brunetto M; Yen TS; Houghton M; Pileri P; Abrignani S
Eur J Immunol; 2004 Oct; 34(10):2834-42. PubMed ID: 15368299
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
Allander T; Forns X; Emerson SU; Purcell RH; Bukh J
Virology; 2000 Nov; 277(2):358-67. PubMed ID: 11080483
[TBL] [Abstract][Full Text] [Related]
3. Host cell responses induced by hepatitis C virus binding.
Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
[TBL] [Abstract][Full Text] [Related]
4. Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2.
Drummer HE; Wilson KA; Poumbourios P
Biochem Biophys Res Commun; 2005 Mar; 328(1):251-7. PubMed ID: 15670777
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins.
Shaw ML; McLauchlan J; Mills PR; Patel AH; McCruden EA
J Med Virol; 2003 Jul; 70(3):361-72. PubMed ID: 12766998
[TBL] [Abstract][Full Text] [Related]
6. The GBV-C envelope glycoprotein E2 does not interact specifically with CD81.
Kaufman TM; McLinden JH; Xiang J; Engel AM; Stapleton JT
AIDS; 2007 May; 21(8):1045-8. PubMed ID: 17457101
[TBL] [Abstract][Full Text] [Related]
7. A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.
Tao W; Xu C; Ding Q; Li R; Xiang Y; Chung J; Zhong J
Virology; 2009 Dec; 395(1):67-76. PubMed ID: 19793603
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.
Nattermann J; Zimmermann H; Iwan A; von Lilienfeld-Toal M; Leifeld L; Nischalke HD; Langhans B; Sauerbruch T; Spengler U
Hepatology; 2006 Oct; 44(4):945-54. PubMed ID: 17006905
[TBL] [Abstract][Full Text] [Related]
9. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.
Rosa D; Saletti G; De Gregorio E; Zorat F; Comar C; D'Oro U; Nuti S; Houghton M; Barnaba V; Pozzato G; Abrignani S
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18544-9. PubMed ID: 16339892
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus (HCV): a review of immunological aspects.
Irshad M; Khushboo I; Singh S; Singh S
Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
[TBL] [Abstract][Full Text] [Related]
11. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
Perrault M; Pécheur EI
Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
[TBL] [Abstract][Full Text] [Related]
13. In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs.
Wunschmann S; Muller HM; Stipp CS; Hemler ME; Stapleton JT
J Infect Dis; 2006 Oct; 194(8):1058-67. PubMed ID: 16991080
[TBL] [Abstract][Full Text] [Related]
14. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a polytopic form of the E1 envelope glycoprotein of Hepatitis C virus.
Migliaccio CT; Follis KE; Matsuura Y; Nunberg JH
Virus Res; 2004 Sep; 105(1):47-57. PubMed ID: 15325080
[TBL] [Abstract][Full Text] [Related]
16. CD81 binding regions of hepatitis C virus remain conserved after liver transplantation.
Lyra AC; Fan X; Di Bisceglie AM
Braz J Infect Dis; 2004 Apr; 8(2):126-32. PubMed ID: 15361990
[TBL] [Abstract][Full Text] [Related]
17. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
Drummer HE; Boo I; Maerz AL; Poumbourios P
J Virol; 2006 Aug; 80(16):7844-53. PubMed ID: 16873241
[TBL] [Abstract][Full Text] [Related]
18. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein.
Heo TH; Lee SM; Bartosch B; Cosset FL; Kang CY
Virus Res; 2006 Oct; 121(1):58-64. PubMed ID: 16725222
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus glycoprotein E2 binding to CD81: the role of E1E2 cleavage and protein glycosylation in bioactivity.
Chan-Fook C; Jiang WR; Clarke BE; Zitzmann N; Maidens C; McKeating JA; Jones IM
Virology; 2000 Jul; 273(1):60-6. PubMed ID: 10891408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]